Lewis Joel has bought 12,272 shares of Galectin Therapeutics Inc [GALT] at $1.57 a share.
Galectin Therapeutics Inc [GALT] disclosed in an SEC Form 4 submission Wednesday, May 31, 2023 that the deal increased Lewis Joel's holding in the company to 884,166.
Galectin Therapeutics Inc [GALT] is a Pharmaceutical Preparations company based in Nevada.
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.